McLaughlin Matthew T E 4
4 · Oxford Immunotec Global PLC · Filed Apr 10, 2019
Insider Transaction Report
Form 4
McLaughlin Matthew T E
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2019-04-08+57,108→ 57,108 totalExercise: $15.97Exp: 2029-04-08→ Ordinary Shares (57,108 underlying) - Award
Ordinary Shares
2019-04-08+26,612→ 26,612 total
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from May 1, 2020 through May 1, 2023.